sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 1347.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 16-Mar-2017
Zeroing in on the Zika virus
Hobman has been announced as one of three Canadian scientists who have received funding from the Canadian Institutes of Health Research (CIHR) for their teams to study the Zika virus. Hobman's lab has been awarded $500,000 over three years to investigate how the virus changes host cells during infection, with the goal of developing antiviral therapies that can be used against the pathogen. There are currently no antivirals or vaccines available to protect against Zika.
Canadian Institute of Health Research, Li Ka Shing Institute of Virology, Women and Children's Health Research Institute

Contact: Ross Neitz
rneitz@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry

Public Release: 16-Mar-2017
European Heart Journal: Acute Cardiovascular Care
Delirium is associated with 5-fold increased mortality in acute cardiac patients
Delirium is associated with a five-fold increase in mortality in acute cardiac patients, according to research published today in European Heart Journal: Acute Cardiovascular Care. Delirium was common and affected over half of acute cardiac patients aged 85 years and older.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 15-Mar-2017
UA part of international alliance to address African antivenom crisis
The African Society of Venimology, the Institute of Biotechnology of the National Autonomous University in Mexico and the VIPER Institute at the University of Arizona partner to provide biotechnology and educational support to confront the snakebite crisis on the African continent.

Contact: George Humphrey
ghumphre@email.arizona.edu
520-626-7301
University of Arizona Health Sciences

Public Release: 15-Mar-2017
Angewandte Chemie
New method for producing leading anti-malarial drug
Researchers at Cardiff University have devised a new way of creating a drug commonly used as the first line of defense against malaria around the world.

Contact: Michael Bishop
bishopm1@cardiff.ac.uk
029-208-74499
Cardiff University

Public Release: 15-Mar-2017
European Heart Journal - Cardiovascular Pharmacotherapy
'Harmless' painkillers associated with increased risk of cardiac arrest
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal - Cardiovascular Pharmacotherapy.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 15-Mar-2017
Science Translational Medicine
Researchers map pathways to protective antibodies for an HIV vaccine
A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 14-Mar-2017
JAMA
Experimental Ebola vaccine regimen induced durable immune response, study finds
A two-vaccine regimen to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published March 14 in JAMA. The investigational vaccines included Ad26.ZEBOV, developed by Janssen Vaccines & Prevention B.V., of the Janssen Pharmaceutical Companies of Johnson & Johnson, and MVA-BN-Filo, developed by Bavarian Nordic. The NIAID supported the development and testing of the experimental vaccines.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 14-Mar-2017
Immunity
Immune molecule protects against Zika virus infection in animal models
A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found. Administering the molecule, called 25-hydroxycholesterol or 25HC, to pregnant mice reduced Zika virus infection in the fetal brain and protected against Zika-induced microcephaly. The work was supported in part by the National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Hillary Hoffman
hillary.hoffman@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 14-Mar-2017
JAMA
Ebola vaccines provide immune responses after 1 year
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

Contact: Matthew D. Snape, M.D.
matthew.snape@paediatrics.ox.ac.uk
The JAMA Network Journals

Public Release: 13-Mar-2017
Georgia State researcher Gets $4.1 million federal grant to develop drug to combat Ebola virus
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
NIH/National Institute of Allergy and Infectious Diseases

Contact: LaTina Emerson
lemerson1@gsu.edu
404-413-1353
Georgia State University

Public Release: 13-Mar-2017
Nature Microbiology
Tick tock: Time to sleep? Sleeping parasite has own internal clock
Researchers from iMM Lisboa have shown that the parasite responsible for sleeping sickness, Trypanosoma brucei, has its own internal clock, which allows it to anticipate daytime alterations of its surrounding environment and become more virulent.

Contact: Ana de Barros
anabarros@medicina.ulisboa.pt
Instituto de Medicina Molecular

Public Release: 13-Mar-2017
Nature Microbiology
Atomic map gives malaria drug new lease on life
Researchers have for the first time mapped how one of the longest-serving malaria drugs works, opening the possibility of altering its structure to make it more effective and combat increasing malaria drug resistance. The study produced a precise atomic map of the frontline antimalarial drug mefloquine, showing how its structure could be tweaked to make it more effective in killing malaria parasites.

Contact: Liz Williams
communications@wehi.edu.au
61-475-751-811
Walter and Eliza Hall Institute

Public Release: 10-Mar-2017
Halting nearsightedness epidemic goal of UH vision scientist
Funded by a $1.9 million grant from the NIH's National Eye Institute, UH College of Optometry's Earl Smith is looking at how certain aspects of indoor lighting affect eye growth and testing a new pharmaceutical agent that has shown promise in slowing the development of myopia.
NIH/National Eye Institute

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston

Public Release: 9-Mar-2017
PLOS Neglected Tropical Diseases
GW researchers develop test to study potency for neglected tropical disease vaccine
Researchers at the George Washington University have developed a way to test recombinant vaccines for their ability to stay effective after years of storage. Their research was published this week in PLOS Neglected Tropical Diseases.

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 9-Mar-2017
American College of Cardiology's 66th Annual Scientific Session
Researchers sound alarm over Zika's potentially harmful heart effects
As the Zika virus continues to spread globally, new evidence has emerged about the virus's potentially detrimental effects on the heart, according to data scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session.

Contact: Katie Glenn
kglenn@acc.org
202-375-6472
American College of Cardiology

Public Release: 8-Mar-2017
New England Journal of Medicine
Yellow fever in the Americas
The large outbreak of yellow fever occurring in rural Brazil deserves careful attention by world health authorities, notes NIAID director Anthony S. Fauci, M.D. Writing in a Perspectives piece for NEJM, Dr. Fauci and his associate Catharine I. Paules, M.D., note that this latest outbreak of a serious mosquito-borne virus comes as Zika virus, which is spread by the same mosquito as yellow fever virus, continues to affect countries throughout the Americas.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Mar-2017
PLOS ONE
High prevalence and incidence of hypertension among rural Africans living with HIV
About 12 percent of people living with HIV in rural Tanzania have hypertension at the moment of HIV diagnosis. An additional 10 percent will develop hypertension during the first months of antiretroviral therapy. This represents an incidence 1.5 times higher than that found in Europe or the United States. The findings, published today in the open-access journal PLOS ONE, come from the Swiss Tropical and Public Health Institute in collaboration with partner institutions in Tanzania, Switzerland and Spain.

Contact: Sabina Beatrice-Matter
sabina.beatrice@unibas.ch
41-797-379-158
Swiss Tropical and Public Health Institute

Public Release: 8-Mar-2017
European Heart Journal
Clinical trial rules should protect patients and results, not operational details
Rules governing the conduct of clinical trials are failing to produce the intended benefits for patients and should be rewritten through a transparent process that involves academic clinical trialists and patient advocates as well as regulators and industry representatives, according to recommendations published today in European Heart Journal.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 8-Mar-2017
European Journal of Heart Failure
Peripartum cardiomyopathy occurs globally and is not a disease of the poor
Peripartum cardiomyopathy occurs globally and is not a disease of the poor, according to research published today in the European Journal of Heart Failure. Cases were reported from many countries for the first time.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 7-Mar-2017
International Sociology
Research finds link between unemployed women trading sex for security and high HIV rates
Dr. Kelly Austin finds that unemployment among young women significantly impacts the proportion of female HIV cases among those aged 15-24 in developing -- especially Sub-Saharan African countries.

Contact: Lauren Stralo
lkw214@lehigh.edu
Lehigh University

Public Release: 7-Mar-2017
Nature Communications
A light rain can spread soil bacteria far and wide, study finds
A good rain can have a cleansing effect on the land. But an MIT study published today in Nature Communications reports that, under just the right conditions, rain can also be a means of spreading bacteria. Using high-resolution imaging, researchers from MIT's Department of Mechanical Engineering observed the effect of raindrops falling on dry soil laden with bacteria.

Contact: Abby Abazorius
abbya@mit.edu
617-253-2709
Massachusetts Institute of Technology

Public Release: 6-Mar-2017
Canadian Medical Association Journal
Zika virus in Canadian travellers more severe than expected
A new study sheds light on the acquisition and features of Zika virus in Canadian travellers, indicating it was as commonly confirmed as dengue in people returning from the Americas and the Caribbean but more severe than expected, according to a new study published in CMAJ (Canadian Medical Association Journal).
CanTravNet

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
800-267-9703
Canadian Medical Association Journal

Public Release: 1-Mar-2017
Genetics
Research shows nature can beat back scientific tinkering with genes of entire species
A University of Kansas researcher and colleagues from Cornell University have revealed daunting challenges to changing the DNA of entire populations of species via the most promising techniques available today to produce 'gene drive.'

Contact: Brendan M. Lynch
brendan@ku.edu
785-864-8855
University of Kansas

Public Release: 1-Mar-2017
JAMA Dermatology
Study defines global burden of skin disease
A study published today in JAMA Dermatology combines the prevalence of skin diseases around the world with their likelihood of creating disability across the lifespan to define the following 10 most challenging conditions (arranged in order of decreasing 'disability-adjusted life years'): dermatitis, acne, hives, psoriasis, viral skin diseases, fungal skin diseases, scabies, melanoma, pyoderma, cellulitis, non-melanoma skin cancer, decubitus ulcer, and alopecia areata.
Bill and Melinda Gates Foundation

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 1-Mar-2017
European Journal of Preventive Cardiology
Benefits of physical activity may outweigh impact of obesity on cardiovascular disease
The benefits of physical activity may outweigh the impact of overweight and obesity on cardiovascular disease in middle-aged and elderly people, according to research published today in the European Journal of Preventive Cardiology. The observational study was conducted in more than 5,000 people aged 55 years and older who were followed-up for 15 years.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Showing releases 151-175 out of 1347.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>